Cytosorbents vs Utah Medical Products
CTSO and UTMD side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CTSO and UTMD compare
Cytosorbents is the larger company, worth 1.4 times as much as Utah Medical Products ($336M against $233M).
Utah Medical Products pays a dividend yielding 1.7%; Cytosorbents does not pay one.
Utah Medical Products scores higher on the StockData Score (10 against 2 for Cytosorbents), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CTSO | UTMD |
|---|---|---|
| Size and price | ||
| Market cap | $336M | $233M |
| Share price | $5.34 | $73.03 |
| Change, 1 year | −63.0% | 27.5% |
| Change, 5 years | −94.9% | −36.8% |
| Beta (5Y) | 0.96 | 0.48 |
| Employees | 129 | 140 |
| StockData Score | ||
| Total score | 2 | 10 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 1 (better) | 0 |
| Performance score | 1 | 1 |
| Health score | 0 | 4 (better) |
| Dividend score | 0 | 2 (better) |
| Valuation | ||
| P/E | – | 22.3× |
| P/S | 9.0× | 6.4× (better) |
| P/B | – | 1.9× |
| EV/EBITDA | – | 14.1× |
| P/FCF | – | 20.3× |
| FCF yield | −2.8% | 4.9% (better) |
| Fair value | – | $76.45 |
| Margin of safety | – | 4.5% |
| Growth | ||
| Revenue growth (TTM) | 3.1% | – |
| Revenue growth, 5Y average | −2.0% | −1.8% (better) |
| EPS growth, 5Y average | – | 3.4% |
| Profitability | ||
| Gross margin | 71.6% (better) | 57.9% |
| Operating margin | −34.7% | 28.4% (better) |
| Net margin | −48.9% | – |
| FCF margin | −25.0% | 31.7% (better) |
| Return on equity | −336% | – |
| Return on invested capital | −73.4% | 23.9% (better) |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Net debt / EBITDA | – | −8.51 |
| Current ratio | 0.66 | 48.62 (better) |
| Altman Z-score | −7.07 | 57.94 (better) |
| Piotroski F-score | 3 | – |
| Dividends and buybacks | ||
| Dividend yield | – | 1.7% |
| Buyback yield | – | 0.80% |
| Shareholder yield | 0.00% | 2.5% (better) |
| Ownership | ||
| Held by institutions | 1.3% | 72.8% |
| Held by insiders | 2.5% | 7.3% |
| Insider net buying, 12 months | $269K (better) | $66.8K |
| Short interest, % of float | 0.22% | 5.1% |
Go deeper
- CTSO stock overview
- CTSO income statement
- CTSO valuation and score
- UTMD stock overview
- UTMD income statement
- UTMD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.